Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | FPR3 | P25089 | 1/20 | 0.39 |
| ▸ | FPR2 | P25090 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29192701 | 0.86 | MAPT (0.52) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL17878013 | 0.85 | SMN1; SMN2 (0.49) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL26101401 | 0.82 | SMN1; SMN2 (0.51) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL17878015 | 0.81 | ALDH1A1 (0.57) | SMN1; SMN2MAPTMEN1KMT2ACYP2C19 | |
| SCHEMBL29311592 | 0.80 | CKS1B (0.53) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL17876415 | 0.80 | CHRM4 (0.45) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL20946394 | 0.79 | KMT2A (0.55) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL21396291 | 0.78 | SMN1; SMN2 (0.54) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL4487502 | 0.77 | KMT2A (0.58) | SMN1; SMN2LMNAMAPTMEN1KMT2A | |
| SCHEMBL13007739 | 0.77 | SMN1; SMN2 (0.53) | SMN1; SMN2LMNAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3027615-B1 | ANTI-INFECTIVE COMPOUNDS | PASTEUR INSTITUT KOREA (KR) | 2021-07-21 | — | — | EP | disclosed |
| US-20160185774-A1 | Anti-Infective Compounds | INSTITUT PASTEUR KOREA (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185774-A1 | Anti-Infective Compounds | RABGGTB, ELANE, SERPINB1 | SMN1; SMN2 4839/4885LMNA 4132/4885MAPT 2660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.